CANC ETF

CANC ETF (Tema Oncology ETF) is managed by Tema Global Limited with $204.4M in net assets. CANC expense ratio is 0.75%, holding 58 positions across sectors including Health Care. Inception date: 2023-08-15.

CANC performance shows a YTD return of 17.38%. The 1-year return is 56.75%. CANC dividend yield stands at 0.05%, paid annually.

CANC top holdings include Revolution Medicines Inc (6.1%), Cogent Biosciences Inc (5.5%), Eli Lilly & Co. (5.4%), Roche Holding Ag Dividend Right Cert (4.6%), Novartis Ag (4.1%). Go to all CANC holdings, CANC sectors, or CANC dividends.

CANC can be compared against other funds. Use CANC overlap to find shared positions, or CANC vs another fund for a side-by-side view. CANC alternatives are available via the screener, along with tax-loss harvesting opportunities.